328 W. Claiborne St.
P.O. Box 964
Monroeville, Alabama 36460
(251) 575-4203
     
Women's Health
Resources
Basic InformationLatest News
Are Women With Parkinson's at a Disadvantage?Ovarian CA Screening Potentially Cost-Effective in the U.S.Just a Little Weight Loss May Cut Breast Cancer RiskFor Breast Cancer Patients, Less Time on Hormonal Meds?Birth Control Pill Tied to Slight Rise in Breast Cancer RiskNew Breast Cancer Drug May Benefit Younger Women, TooHealth Tip: 11 Harmful Effects of SmokingAre Women Naturally Fitter Than Men?5 Things You Should Know About Cervical CancerModern Times May Mean Weaker Biceps for WomenHealth Tip: Identifying Common Bladder Problems in WomenIs It Time to Scrap the Pap Test?Health Tip: How to Clean a Breast PumpThe Silver Lining Behind Household ChoresHealth Tip: Diabetes Affects Women DifferentlyHealth Tip: Help Prevent OsteoporosisWomen Still Want Annual MammogramsChronic Conditions Increasing Among Childbearing WomenDiabetes, High Blood Pressure While Pregnant Spells Trouble Later OnBreathing Dirty Air May Raise Miscarriage RiskWith Stress and Trauma Come Excess WeightWeighing Too Much or Too Little When Pregnant Can Be RiskyMany Women Miss Out on Lifesaving CPRPatients Use ~Half of Opioids Prescribed After HysterectomyEclampsia Tied to Increased Relative Risk of Seizure DisorderLow-Fat Diet May Cut Pancreatic Cancer Risk for Overweight Older WomenKnow the Signs of Ovarian Cancer and Your RisksRisk of Breast Cancer's Return Can Linger for DecadesUSPSTF Posts Osteoporosis Screening RecommendationsIUD May Lower Cervical Cancer RiskOlder Women Can 'Walk Away From the Grim Reaper'Health Tip: Deciphering Cosmetic LabelsPostmenopausal Estradiol Linked to Blunted Cortisol ResponsesHealth Tip: Supporting Breast-feeding Moms on the JobBad Hot Flashes, Sleep Apnea Often Go TogetherA Teen Mom's Stress May Harm Her HeartBreast-Feeding Bond Lingers for MomBone Strength + Bone Mineral Density Screening Cost-EffectiveRecommendations Developed for Trial of Labor After C-SectionNew ACOG Guidance on Long-Acting Reversible ContraceptivesSkinny in 20s, Earlier Menopause Later?Many High-Risk Women Skip MRI Breast Cancer ScreeningsJoan Lunden's Breast Cancer Journey: 'You Feel So Vulnerable'What You May Not Know About Ovarian CancerIncision Length Linked to Pain After CesareanWomen Falling Short on Birth Defect PreventionMore Women Choose Breast Reconstruction After MastectomyBreast Cancer Screenings Still Best for Early DetectionBeauty Standards Evolved From 1990 to 2017Hormone Therapy May Be OK for Women With Migraines
LinksSelf-Help Groups
Related Topics

Wellness and Personal Development
Mental Disorders

Hormone Therapy May Be OK for Women With Migraines

HealthDay News
by By Amy Norton
HealthDay Reporter
Updated: Oct 11th 2017

new article illustration

WEDNESDAY, Oct. 11, 2017 (HealthDay News) -- Women who suffer from migraines may be able to safely use hormone therapy to treat menopause symptoms, a new study suggests.

The study of 85,000 U.S. women found no evidence that hormone therapy carried a particular risk of heart attack or stroke among those with a history of migraine headaches.

That possibility has been a concern, mainly based on studies of younger women with migraines. Those studies linked hormonal birth control pills to a small risk of stroke, particularly among women whose migraines feature "aura" symptoms -- most often, visual disturbances such as seeing zigzag lines or bright flashes.

Less has been known about any risks of hormone replacement therapy, said Dr. Jelena Pavlovic, the lead researcher on the new study.

"It appears safe for women with migraines to use hormone therapy, in terms of their cardiovascular risk," said Pavlovic, an assistant professor of neurology at Albert Einstein College of Medicine in New York City.

That said, she added, the general advice for women is to talk to their doctor about the benefits and risks of hormone therapy -- and to start "low and slow."

That's the advice of groups such as the American College of Obstetricians and Gynecologists. They recommend that women only use hormone therapy at the lowest dose and for the shortest length of time needed to ease menopause symptoms such as hot flashes and night sweats.

Doctors have been cautious about menopausal hormone therapy ever since 2002, when results were reported from a large U.S. government study called the Women's Health Initiative (WHI).

It found that women who were given menopausal hormone therapy -- with estrogen and progestin, or estrogen alone -- faced health risks. They included heightened odds of breast cancer, blood clots and stroke.

Since then, studies have suggested the situation is more nuanced. Hormone therapy seems safer, for example, for relatively younger women at the beginning of menopause. (Women in the WHI were, on average, in their early 60s.)

It's remained unclear, Pavlovic said, whether women with migraines can safely go on hormone therapy.

It's estimated that migraines affect 1 in every 4 women, she said.

For the new study, Pavlovic and her colleagues combed through data from the WHI.

They found that of more than 85,000 participants with no history of heart disease or stroke, 8,800 women had suffered from migraines. During the study period, just over 1,100 women overall developed heart disease, a stroke or blood clots in the legs or lungs.

The researchers found no evidence that women with migraines were more likely than others to suffer those complications. And migraine sufferers who were given hormone therapy faced no greater risks than those given a placebo.

Dr. Huma Sheikh is an assistant professor of neurology at Mount Sinai's Icahn School of Medicine in New York City.

She said the new findings are "encouraging."

At one time, Sheikh said, many doctors treating women with migraines would have considered hormones to be "off the table."

"But now they're becoming more open to it," she said. That's partly because hormones are prescribed at lower doses today versus years ago, Sheikh noted.

The current study has limitations, Pavlovic acknowledged. For one, it looked at women's risk of cardiovascular problems overall, and not their risk of stroke specifically.

The researchers were also unable to look separately at women who had migraines with aura.

Sheikh said further studies are needed to validate these findings -- and to sort out whether certain women with migraines might face risks from hormone therapy.

For now, she suggested first trying nonhormonal ways to manage menopausal symptoms.

If women do consider hormone therapy, Sheikh added, their overall health has to be taken into account -- including whether they have risk factors for heart disease and stroke, such as high blood pressure and diabetes.

The findings were scheduled for presentation this week at the annual meeting of the North American Menopause Society, in Philadelphia. Studies presented at meetings are usually considered preliminary until published in a peer-reviewed journal.

More information

The U.S. National Institute on Aging has more on managing menopause symptoms.




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net